There is also a Wegovy pill, which contains the same drug, but its available at a different dose and is approved to treat obesity
doi: 10.1016/j.neuint.2020.104693 Summary Keywords general anesthesia, neurotoxicity, neurodevelopmental impairment, cognitive dysfunction, developing brain Citation Niu Y, Yan J and Jiang H (2022) Anesthesia and developing brain: What have we learned from recent studies
Monotherapy with GLP-1 receptor agonist, lixisenatide, significantly improves glycaemic control in type 2 diabetic patients [abstract 830]
If you are uncomfortable with the current valuations of LLY and NVO (dont be, theyre fine), I would recommend looking into more downstream effects where tailwinds provided by these drugs may not be priced in to expectations by the market and/or consensus estimates yet
Some people are more likely to run low, including: Vegans and vegetarians People with digestive issues (like IBS or coeliac) Older adults Anyone on certain medications People recovering from illness We dont guess
10.2337/dc14-0024 49